Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Lorefice

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Nutrients|November 27, 2024
Propionic Acid Impact on Multiple Sclerosis: Evidence and ChallengesLorena Lorefice, Magdalena Zoledziewska
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 3, 2025
Treating comorbidities in multiple sclerosis is disease modifying: YesLorena Lorefice, Robert Zivadinov
Neurodegenerative Disease Management|November 27, 2024
Gut microbiota and multiple sclerosis: a potential diagnostic and prognostic marker?Magdalena Zoledziewska, Lorena Lorefice
Annals of Neurology|November 21, 2025
Frailty across Neurological Diseases: Why Sex and Gender MatterLorena Lorefice, Maria Teresa Pellecchia
Journal of Neurology, Neurosurgery, and Psychiatry|June 12, 2025
Silent burden: recognising and managing invisible symptoms in neuromyelitis opticaLorena Lorefice, Antonio Carotenuto, Giuseppe Fenu
Multiple Sclerosis and Related Disorders|June 24, 2024
Intermittent and periodic fasting - Evidence and perspectives in multiple sclerosisLorena Lorefice, Maristella Pitzalis, Magdalena Zoledziewska
Drug Design, Development and Therapy|May 19, 2021
An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple SclerosisMarzia Fronza, Lorena Lorefice, Jessica Frau, et al.
Expert Review of Neurotherapeutics|July 29, 2016
Perception of risk and shared decision making process in multiple sclerosisEleonora Cocco, Alberto Caoci, Lorena Lorefice, et al.
Frontiers in Immunology|October 25, 2021
Infections and Multiple Sclerosis: From the World to Sardinia, From Sardinia to the WorldJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Multiple Sclerosis and Related Disorders|March 31, 2023
Disease-modifying therapy for multiple sclerosis: Implications for gut microbiotaSilvy Pilotto, Magdalena Zoledziewska, Giuseppe Fenu, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Nutrients|November 27, 2024
Propionic Acid Impact on Multiple Sclerosis: Evidence and ChallengesLorena Lorefice, Magdalena Zoledziewska
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 3, 2025
Treating comorbidities in multiple sclerosis is disease modifying: YesLorena Lorefice, Robert Zivadinov
Neurodegenerative Disease Management|November 27, 2024
Gut microbiota and multiple sclerosis: a potential diagnostic and prognostic marker?Magdalena Zoledziewska, Lorena Lorefice
Annals of Neurology|November 21, 2025
Frailty across Neurological Diseases: Why Sex and Gender MatterLorena Lorefice, Maria Teresa Pellecchia
Journal of Neurology, Neurosurgery, and Psychiatry|June 12, 2025
Silent burden: recognising and managing invisible symptoms in neuromyelitis opticaLorena Lorefice, Antonio Carotenuto, Giuseppe Fenu
Multiple Sclerosis and Related Disorders|June 24, 2024
Intermittent and periodic fasting - Evidence and perspectives in multiple sclerosisLorena Lorefice, Maristella Pitzalis, Magdalena Zoledziewska
Drug Design, Development and Therapy|May 19, 2021
An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple SclerosisMarzia Fronza, Lorena Lorefice, Jessica Frau, et al.
Expert Review of Neurotherapeutics|July 29, 2016
Perception of risk and shared decision making process in multiple sclerosisEleonora Cocco, Alberto Caoci, Lorena Lorefice, et al.
Frontiers in Immunology|October 25, 2021
Infections and Multiple Sclerosis: From the World to Sardinia, From Sardinia to the WorldJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Multiple Sclerosis and Related Disorders|March 31, 2023
Disease-modifying therapy for multiple sclerosis: Implications for gut microbiotaSilvy Pilotto, Magdalena Zoledziewska, Giuseppe Fenu, et al.
Pageof 10